Edition:
United Kingdom

Innate Pharma SA (IPH.PA)

IPH.PA on Paris Stock Exchange

4.61EUR
3:39pm BST
Change (% chg)

€-0.03 (-0.73%)
Prev Close
€4.64
Open
€4.61
Day's High
€4.64
Day's Low
€4.59
Volume
24,245
Avg. Vol
121,553
52-wk High
€10.67
52-wk Low
€4.33

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.60 December 19 Sep 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 3 3
(2) OUTPERFORM 4 4 4 4
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 1.89 1.89

Consensus Estimates Analysis

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 1 11.00 11.00 11.00 --
Year Ending Dec-18 5 47.45 68.00 34.70 67.91
Year Ending Dec-19 5 77.39 155.00 40.00 74.25
Earnings (per share)
Quarter Ending Dec-18 1 -0.60 -0.60 -0.60 --
Year Ending Dec-18 6 -0.48 -0.12 -0.88 0.08
Year Ending Dec-19 5 -0.06 0.99 -0.76 0.40
LT Growth Rate (%) 1 74.60 74.60 74.60 -11.60

Historical Surprises

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 6.00 14.97 8.97 149.43
Quarter Ending Dec-17 1.50 16.10 14.60 973.27
Quarter Ending Jun-17 13.40 13.97 0.57 4.28

Consensus Estimates Trend

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 11.00 6.00 6.00 6.00 --
Year Ending Dec-18 47.45 48.05 50.62 50.62 67.91
Year Ending Dec-19 77.39 89.26 99.81 99.81 74.25
Earnings (per share)
Quarter Ending Dec-18 -0.60 -- -- -- --
Year Ending Dec-18 -0.48 -0.65 -0.61 -0.61 0.08
Year Ending Dec-19 -0.06 -0.17 0.01 0.01 0.40

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 1 0 1 0
Year Ending Dec-18 2 0 2 0
Year Ending Dec-19 1 0 1 0
Earnings
Quarter Ending Dec-18 -- -- -- --
Year Ending Dec-18 2 0 2 0
Year Ending Dec-19 2 0 2 0